Researchers are currently developing a drug for COVID-19 treatment and its Phase II trial has verified a high 90-percent success in recovery rate. Patients participating in the study recovered within days.
An extensive study has been conducted to examine the use of COVID-19 drug Ivermectin for the virus's treatment, in the middle of guidelines worldwide, warning against the administration of the medicine.
According to MIT research, ultrasound scans, the machines used to monitor the growth of a fetus inside a mother's womb, can destroy coronavirus cells by forcing the virus's surface to tear apart and implode.
The 40-year-old antidepressant drug, Fluvoxamine is currently being tested as a potential treatment for COVID-19. It has been authorized by the FDA to be considered for those at high risk of suffering severe symptoms of COVID-19.